previous compound ID: 64 next compound
InChIKey: QELUYTUMUWHWMC-UHFFFAOYSA-N
SMILES: CC1=NN(C(=O)C1)C2=CC=CC=C2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 32
"M Eda" "MF Springsteel" "MH Nantz" "AS Verkman" "K By" "LJ Galietta" "MJ Haddadin" "MJ Kurth" "EJ Niedzinski"
ReferenceID: 53
"GW Carlile" "JW Hanrahan" "D Rotin" "R Robert" "DY Thomas" "J Goepp" "E Matthes" "B Kus" "J Liao" "SD Macknight"

chemical graph of compound 64





CID is 4021
synonyms found at PubChem are:
edaravone, 89-25-8, Radicut, 1-Phenyl-3-methyl-5-pyrazolone, 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE, Norphenazone, Developer Z, Methylphenylpyrazolone, Norantipyrine, C.I. Developer 1, MCI-186, Phenylmethylpyrazolone, 3-Methyl-1-phenyl-5-pyrazolone, Phenyl methyl pyrazolone, Radicava, 1-Phenyl-3-methyl-5-oxo-2-pyrazoline, 1-Phenyl-3-methylpyrazolone, CI Developer 1, 3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-, edarabone, 3-Methyl-1-phenyl-1H-pyrazol-5(4H)-one, edaravone(jan), 1-Phenyl-3-methylpyrazolone-5, 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one, 3-Methyl-1-phenylpyrazol-5-one, 3-Methyl-1-phenyl-2-pyrazoline-5-one, NCI-C03952, 2-Pyrazolin-5-one, 3-methyl-1-phenyl-, 5-Pyrazolone, 3-methyl-1-phenyl-, 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, 5-methyl-2-phenyl-4H-pyrazol-3-one, Monopyrazolone, NSC 12, Edaravone (MCI-186), 1-Fenyl-3-methyl-2-pyrazolin-5-on, CCRIS 512, Radicut (TN), 3-methyl-1-phenyl-4,5-dihydro-1H-pyrazol-5-one, CHEBI:31530, HSDB 4102, 1-Fenyl-3-methyl-2-pyrazolin-5-on [Czech], EINECS 201-891-0, IN1263, BRN 0609575, AI3-03557, MLS000069602, QELUYTUMUWHWMC-UHFFFAOYSA-N, NSC-2629, (MCI-186), NSC-26139, CDS1_000986, NCGC00164015-01, SMR000059020, M0687, DSSTox_CID_1130, DSSTox_RID_75961, DSSTox_GSID_21130, AE-641/00371017, 3-METHYL-1-PHENYL-2-PYRAZOLIN-5-ONE (MCI-186), WLN: T5NMV DHJ BR& E1, 1-Phenyl-3-methyl-2-pyrazolin-5-on, CAS-89-25-8, Edaravone [INN], 3H-Pyrazol-3-one,4-dihydro-5-methyl-2-phenyl-, SR-01000000135, MCI 186, Radicava (TN), Radicut;MCI-186, PubChem13301, Spectrum_000267, Tocris-0786, Edaravone (JAN/INN), Edaravone [USAN:INN], AC1Q2PHG, AC1Q6EYP, Maybridge1_005738, Opera_ID_1057, Spectrum2_001574, Spectrum3_000971, Spectrum4_001091, Spectrum5_001217, Edaravone (JP17/INN), D06DLI, EC 201-891-0, AC1L1H8H, SCHEMBL4704, BSPBio_001235, BSPBio_002601, KBioGR_000575, KBioGR_001502, KBioSS_000575, KBioSS_000747, KSC448M1D, MLS001146878, MLS002415675, MLS006011753, DivK1c_001018, DivK1c_002026, SPECTRUM1503635, SPBio_001508, CHEMBL290916, DTXSID9021130, BCBcMAP01_000127, CTK3E8611, HMS503K17, HMS557M18, KBio1_001018, KBio2_000575, KBio2_000747, KBio2_003143, KBio2_003315, KBio2_005711, KBio2_005883, KBio3_001029, KBio3_001030, KBio3_001821, NSC2629, edaravone and MCI-186 and PMP, MolPort-000-182-197, NINDS_001018, BCPP000246, Bio1_000438, Bio1_000927, Bio1_001416, Bio2_000448, Bio2_000928, HMS1362M17, HMS1792M17, HMS1990M17, HMS2234M19, HMS3266F04, HMS3403M17, HMS3654L15, Pharmakon1600-01503635, ACT07289, BCP26336, HY-B0099, KS-00000X6I, NSC26139, Tox21_112077, Tox21_201747, Tox21_302819, BBL011741, BDBM50200541, CCG-39352, MFCD00003138, NSC758622, s1326, STK201315, ZINC18203737, 3-methyl-1-phenyl-2-pyrazolin-5one, AKOS000313817, Tox21_112077_1, AC-4745, BCP9000635, CS-1832, DB12243, LS-1892, MCI-186, Radicut, 89-25-8, NE10266, NSC-758622, RL05601, RTR-028045, IDI1_001018, IDI1_002203, 1-PEHNYL-3-METHYL-5-PYRAZALONE, NCGC00018218-01, NCGC00018218-02, NCGC00018218-03, NCGC00018218-04, NCGC00018218-05, NCGC00018218-06, NCGC00018218-07, NCGC00018218-08, NCGC00018218-10, NCGC00018218-17, NCGC00022665-02, NCGC00022665-04, NCGC00022665-05, NCGC00022665-06, NCGC00256515-01, NCGC00259296-01, 4CA-0486, AJ-70469, AN-11638, BC205186, SC-13582, ST012744, SBI-0051836.P002, AB2000046, DB-002517, KB-183502, ST2410773, TR-028045, AM20060748, FT-0608243, 5-methyl-2-phenyl-2,4-dihydro-3-pyrazolone, 5-methyl-2-phenyl-2,4-dihydropyrazol-3-one, 3-Methyl-1-phenyl-2-pyrazoline-5-one, 99%, 4E-901, 5-methyl-2-phenyl-2,4-dihydro-pyrazol-3-one, C13008, D01552, AB00375776_14, AB00375776_15, 2 4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one, 2,4-dihydro-2-phenyl-5-methyl-3H-pyrazol-3-one, I01-2810, Q-200386, SR-01000000135-2, SR-01000000135-3, SR-01000000135-5, 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one #, BRD-K35458079-001-04-2, BRD-K35458079-001-12-5, BRD-K35458079-001-23-2, Z50145861, F0391-0021, 3-Methyl-1-phenyl-2-pyrazoline-5-one, SAJ special grade, 3-Methyl-1-phenyl-2-pyrazoline-5-one, purum, >=98.0% (NT), 5-Methyl-2-phenyl-2,4-dihydro-3H-pyrazol-3-one (Edaravone), Phenazone impurity A, European Pharmacopoeia (EP) Reference Standard, Antipyrine Related Compound A, United States Pharmacopeia (USP) Reference Standard, InChI=1/C10H10N2O/c1-8-7-10(13)12(11-8)9-5-3-2-4-6-9/h2-6H,7H2,1H, 115566-83-1, 12235-58-4, 206195-95-1, 52224-17-6, 62495-97-0, 72134-66-8